Biosimilar Humira Goes on Sale in Europe, Widening Gap With U.S.

Cheaper copies of the world’s biggest-selling drug will roll out across Europe after a key European patent for Humira expires, but U.S. patients and insurers will have to wait to access less-expensive versions of the blockbuster drug.

from WSJ.com: US Business https://ift.tt/2P4eDnu
via IFTTT